Business · 03/11/20261 min read
Sobi to present new gout data at ACR Convergence 2026
Summary
STOCKHOLM, Nov. 3, 2026 — Sobi® (STO: SOBI) today announced that six abstracts covering pozdeutinurad (AR882), nanoencapsulated sirolimus plus pegadricase (NASP) and uncontrolled gout will be presented…